King’s Daughters has been selected to participate in a large-scale,
pragmatic clinical trial to evaluate the effect of health system-level
quality improvement compared with usual care on heart failure outcomes
and heart failure quality-of-care metrics.
CONNECT – HF Care
OptimizatioN Through PatieNt and Hospital
Trial for Heart Failure (CONNECT – HF) is sponsored by Duke University
in collaboration with Duke Clinical Research Institute.
The CONNECT – HF study purpose is to improve outcomes and lower readmission
rates for chronic Heart Failure patients through both digital patient
involvement and hospital quality improvement interventions. King’s
Daughters is randomized to the most involved arm, which includes a dual
approach to improved quality measures for our heart failure patients.
King’s Daughters will work with Duke researchers to examine and analyze
its current discharge protocols for heart failure patients and choose
one or two global quality improvement interventions to be implemented
for those patients. KDMC will work with quality improvement, cardiology,
hospitalists and outpatient services to identify and implement the intervention(s)
determined to be most beneficial to our population.
All enrolled research patients will be given the option to enroll in a
digital program, HealthStar, that will involve using an app, a digital
scale and pillbox to help ensure compliance with treatment plans. Although
this is not mandatory, enrolled patients will be encouraged to participate
The study includes quality of life assessments at six weeks and at 3, 6
and 12 months after hospital discharge.
For more information on the CONNECT – HF study, please contact King’s
Daughters research nurse Jenny Nunley, RN, at (606) 408-1726.